No evidence of fibrosis regression in HCV/HIV co-infected and HCV monoinfected participants up to 3 years after achieving SVR with DAA treatment: Interim results for the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
Peters, M., Kang, M., Murphy, R., Matining, R., Rosenberg, W., Wyles, D.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)31348-5
Date:
April, 2018
File:
PDF, 63 KB
english, 2018